tiprankstipranks
Tenon Medical’s Q3 2024 Earnings and Strategic Progress
Company Announcements

Tenon Medical’s Q3 2024 Earnings and Strategic Progress

Tenon Medical, Inc. ( (TNON) ) has released its Q3 earnings. Here is a breakdown of the information Tenon Medical, Inc. presented to its investors.

Pick the best stocks and maximize your portfolio:

Looking forward, Tenon Medical remains optimistic about its growth prospects. The company is focusing on leveraging its recent clinical data and new product introductions to drive future revenue growth. With the full commercial launch of the Catamaran SE SI Joint Fusion System expected in early 2025, Tenon aims to continue its trajectory of innovation and expansion in the SI joint treatment market.

Related Articles
TheFlyTenon Medical price target lowered to $8 from $22 at Maxim
TheFlyTenon Medical reports Q3 EPS ($3.63), consensus ($4.23)
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App